These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 33771797)

  • 1. Diabetes: is it time to flatten the curve?
    Blake S
    Br J Gen Pract; 2021 Apr; 71(705):174. PubMed ID: 33771797
    [No Abstract]   [Full Text] [Related]  

  • 2. New-onset diabetes in "long COVID".
    Sathish T; Anton MC; Sivakumar T
    J Diabetes; 2021 Aug; 13(8):693-694. PubMed ID: 33893710
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19: time to flatten the infodemic curve.
    Tentolouris A; Ntanasis-Stathopoulos I; Vlachakis PK; Tsilimigras DI; Gavriatopoulou M; Dimopoulos MA
    Clin Exp Med; 2021 May; 21(2):161-165. PubMed ID: 33417084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus and SARS-CoV-2-related mortality: the impact of acute hyperglycemic crises and some further considerations.
    Patoulias D; Katsimardou A; Papadopoulos C; Doumas M
    Acta Diabetol; 2021 Jan; 58(1):125-126. PubMed ID: 32816107
    [No Abstract]   [Full Text] [Related]  

  • 5. Nasopharyngeal SARS-CoV-2 viral RNA shedding in patients with diabetes mellitus.
    Cano E; Corsini Campioli C; O'Horo JC
    Endocrine; 2021 Jan; 71(1):26-27. PubMed ID: 33033947
    [No Abstract]   [Full Text] [Related]  

  • 6. Diabetes and COVID-19; a Review of Possible Mechanisms.
    Moradi-Marjaneh R; Asgharzadeh F; Khordad E; Marjaneh MM
    Curr Pharm Des; 2021; 27(21):2522-2527. PubMed ID: 33655850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis and Type 2 Diabetes Mellitus: An Inflammatory Danger Signal in the Time of Coronavirus Disease 2019.
    Wilkinson RJ
    Clin Infect Dis; 2021 Jan; 72(1):79-81. PubMed ID: 32533824
    [No Abstract]   [Full Text] [Related]  

  • 8. New Coronavirus (SARS-CoV-2): advances to flatten the curve the prison population.
    Matos MA
    Rev Soc Bras Med Trop; 2020; 53():e20200219. PubMed ID: 32491063
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to: Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity?
    Lippi G; Sanchis-Gomar F; Henry BM
    J Diabetes; 2021 Feb; 13(2):179-180. PubMed ID: 33128349
    [No Abstract]   [Full Text] [Related]  

  • 10. Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity?
    Sathish T; de Mello GT; Cao Y
    J Diabetes; 2021 Feb; 13(2):177-178. PubMed ID: 33107708
    [No Abstract]   [Full Text] [Related]  

  • 11. Recommendations for the care of patients with diabetes mellitus with risk factors or established cardiovascular disease and SARS-CoV-2mellitus con factores de riesgo o enfermedad cardiovascular establecida y SARS-CoV-2.
    Alcocer-Gamba MA; Gutiérrez-Fajardo P; Sosa-Caballero A; Cabrera-Rayo A; Faradji-Hazan RN; Padilla-Padilla FG; Garnica-Cuellar JC; Hernández-Arispe LM; Reyes-Cianeros FA; León-Suárez A; de-Jesús-Rivera J; Mancillas-Adame L; Gaxiola-Macias M; Márquez-Rodríguez E; Miranda-Malpica E; Sanchez-Pedraza V; Lara-Martínez DS; Segovia-Palomo A; Nava-Hernández A; Rivera-Reyes R
    Arch Cardiol Mex; 2020; 90(Supl):77-83. PubMed ID: 32523151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covid-19 and Diabetes Mellitus.
    Attri B; Gupta Y; Tandon N
    Natl Med J India; 2021; 34(3):129-131. PubMed ID: 34825533
    [No Abstract]   [Full Text] [Related]  

  • 13. Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte.
    D'Onofrio N; Scisciola L; Sardu C; Trotta MC; De Feo M; Maiello C; Mascolo P; De Micco F; Turriziani F; Municinò E; Monetti P; Lombardi A; Napolitano MG; Marino FZ; Ronchi A; Grimaldi V; Hermenean A; Rizzo MR; Barbieri M; Franco R; Campobasso CP; Napoli C; Municinò M; Paolisso G; Balestrieri ML; Marfella R
    Cardiovasc Diabetol; 2021 May; 20(1):99. PubMed ID: 33962629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of COVID-19 vaccines and major considerations for diabetic patients.
    Soltani S; Zandi M; Shiri Aghbash P; Rezaei M; Mohammadzadeh N; Afsharifar A; Poortahmasebi V
    Biotechnol Appl Biochem; 2022 Feb; 69(1):30-40. PubMed ID: 33179788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can scientists use simple infographics to convince? Effects of the "flatten the curve" charts on perceptions of and behavioral intentions toward social distancing measures during the COVID-19 pandemic.
    Li N; Molder AL
    Public Underst Sci; 2021 Oct; 30(7):898-912. PubMed ID: 34448434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TB and COVID-19: paying attention to diabetes mellitus.
    Harries AD; Kumar AMV; Satyanarayana S; Lin Y; Dlodlo RA; Khogali M; Zachariah R; Kapur A
    Trans R Soc Trop Med Hyg; 2021 Jun; 115(6):600-602. PubMed ID: 34075400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 infection of the pancreas promotes thrombofibrosis and is associated with new-onset diabetes.
    Qadir MMF; Bhondeley M; Beatty W; Gaupp DD; Doyle-Meyers LA; Fischer T; Bandyopadhyay I; Blair RV; Bohm R; Rappaport J; Lazartigues E; Heide RSV; Kolls JK; Qin X; Mauvais-Jarvis F
    JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34241597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation and hypercoagulopathy are predominant risk factors of severity in COVID-19 patients with diabetes mellitus: Summary of a meta-analysis.
    Dhar SK; Sachdeva K; Das M
    Diabetes Metab Syndr; 2021; 15(2):639-641. PubMed ID: 33676871
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter to the Editor From Woolcott and Castilla-Bancayán: "Diabetes Increases Severe COVID-19 Outcomes Primarily in Younger Adults: Age and Diabetes in COVID-19 Severity".
    Woolcott OO; Castilla-Bancayán JP
    J Clin Endocrinol Metab; 2021 Nov; 106(12):e5273-e5274. PubMed ID: 34363481
    [No Abstract]   [Full Text] [Related]  

  • 20. [The agreed experts' position of the Eurasian Association of Therapists on tactics of management of patients with comorbid pathology infected with SARS-Cov-2].
    Arutiunov GP; Tarlovskaia EI; Koziolova NA; Boldina MV; Batiushin MM; Ametov AS; Arutiunov AG; Belevskii AS; Galstian GR; Grigor'eva NI; Dzhunusbekova GA; Esaian AM; Mal'chikova SV; Mit'kovskaia NP; Mkrtumian AM; Orlova IA; Petrova MM; Rebrov AP; Ruzanov DI; Salukhov VV; Sisakian AS; Skibitskii VV; Sugraliev AB; Fomin IV; Khalimov IS; Chesnikova AI; Shaposhnik II; Shestakova MV
    Ter Arkh; 2020 Oct; 92(9):108-124. PubMed ID: 33346439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.